Another Look at 2017 Securities Litigation Against Life Sciences Companies

As I have previously noted, the elevated number of securities class action lawsuits against life sciences companies was an important factor in the increase of securities lawsuit filings in 2017. The significant volume of securities suits involving life sciences companies has been the subject of focused analysis, as discussed here. Now the Sidley Austin law firm has released its exhaustive review of the 2017 securities litigation against life sciences companies. Among other things, the report finds that while the numbers of securities suit filings against life sciences companies has increased in recent years, the companies are faring worse at the dismissal motion stage in the district courts relative to the most recent years. The report summary can be found here. The full report can be found here.   The 2017 Filings According to the Sidley report, the volume of new securities lawsuit filings against life sciences companies has been increasing over the past three years, from…

Read more detail on Recent Securities Law posts –

This entry was posted in Securities Law and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply